Latest filing published 01 Jun 2022 for Better Therapeutics, Inc., €781.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Justin Zamirowski: trading record in brief
Justin Zamirowski, listed as senior executive, appears in our data through filings on Better Therapeutics, Inc. shares, published by SEC (Form 4). We count 2 filings; the first trade dates from 16 May 2022 and the latest from 27 May 2022.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 1 June 2022, the filings show an option exercise worth €781 in Better Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Justin Zamirowski
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,677 shares@ US$0.50100.0% of flowCommon StockSEC:0000899243-22-020438:0
- 35,236 shares@ €0.47995.6% of flowCommon StockSEC:0000899243-22-018628:0
2 of 2 declarations
